• Mon news: Ventyx gets boost from Sanofi. PhRMA IRA legal challenge gets new life. AZ breast cancer drug disappoints. Teva’s once-monthly schizophrenia med. AZ gets FDA approval for first self-administered flu vaccine. See more on our front page

Let's get real re akynzeo

Anonymous

Guest
Unless the reps can talk about the financial piece of Akynzeo, it is basically impossible to sell. Frequent question is why would I Rx this? What is the benefit? Aloxi and emend works well together and they get the IV reimbursement.

Reps need to show a financial spreadsheet showing how an account can make $ using akynzeo. That is not allowed in this day and age of pharma. Shame
 

<



















































Wait til Tesaro hypes safety of Rolapitant. They will hammer big increases in common chemo blood levels with Akynzeo. No inhibition of CYP 3A4 with theirs. If good contract and samples, watch out.
 
















Why don't we have samples? Why don't we have samples? Anyone?

You think the reason they're not using is because they don't know how well Aloxi and a NK1 work when combined? Millions would be spent to create samples and there's no evidence of superiority. A longer half life doesn't mean better efficacy. That's basic science
 




Why don't we have samples? Why don't we have samples? Anyone?

You think the reason they're not using is because they don't know how well Aloxi and a NK1 work when combined? Millions would be spent to create samples and there's no evidence of superiority. A longer half life doesn't mean longer efficacy. That's basic science